Advanced Search
MyIDEAS: Login to save this paper or follow this series

Les rapprochements stratégiques inter-firmes le cas de l’industrie pharmaceutique (Strategic partnerships between firms the case of the pharmaceutical industry)

Contents:

Author Info

  • Mohammed Benmahidi

    ()
    (labrii, ULCO)

Registered author(s):

    Abstract

    Face à l’environnement global incertain et une globalisation accélérée des marchés, la vie économique est marquée ces dernières années par un comportement stratégique des firmes sur les marchés. Il s’agit ici de la croissance remarquable des accords de coopération. Dans la littérature économique, ce phénomène a été analysé en terme de coût de transaction généré lors de l’organisation des activités économiques par les firmes. En plus, la coopération a été également expliquée en terme de similitude et/ou de complémentarité des activités de la firme. En revanche, le pouvoir explicatif de ces approches théoriques de la coopération est limité en raison de l’unité de mesure prise en compte dans le choix des structures d’organisationnelles. En effet, vu l’intensité de la concurrence sur les marchés et l’incertitude qui règne, les firmes n’ont plus le temps d’arbitrer entre marché-coopération-hiérarchie. Nous assistons désormais à des coopérations plus globalisées et plus complexes tels que le sont les coalitions et les réseaux inter-firmes. Ce développement remarquable des accords de coopération est essentiellement constaté dans les secteurs intensifs en R&D. Ceci étant, le secteur bio-pharmaceutique constitue un modèle idéal pour appliquer cette nouvelle structure des marchés mondiaux de plus en plus consolidée sous forme de coalition et de réseaux inter-firmes. Facing an uncertain global environnement and an accelerated globalization of markets, the economic context has been characterized during these last years by a srategic behaviour of firms. It concerns the notable increase of cooperation agreements. In the economic literature this phenomenon has been analysed in terms of transaction costs generated by firms in their economic activities. Moreover, the cooperation has also been explained in terms of similarity and complementarity of firms’ activities. On the other hand, the explanatary power of these theoretical approaches of cooperation is limited, owing to the measurement unit taken into account for the choice of organisational structures. Indeed, regarding competition intensity on the markets and uncertainty, firms have no more time to arbitrate between market - cooperation - hierarchy. From now on, we notice that the cooperations are more globalized and more complex, just as the coalitions and the interfirm networks. This outstanding developement of cooperation agreements is more unable in R&D intensive sectors. The biopharmaceutical sector appears like an ideal example to implement this new structure of global market through the creation of iner-firm networks.

    Download Info

    If you experience problems downloading a file, check if you have the proper application to view it first. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.
    File URL: http://riifr.univ-littoral.fr/wp-content/uploads/2007/04/doc90.pdf
    Download Restriction: no

    Bibliographic Info

    Paper provided by Laboratoire de Recherche sur l'Industrie et l'Innovation. ULCO / Research Unit on Industry and Innovation in its series Working Papers with number 90.

    as in new window
    Length: 23 pages
    Date of creation: Dec 2004
    Date of revision:
    Publication status: Published in Cahiers du Lab.RII, Décembre 2004
    Handle: RePEc:rii:riidoc:90

    Contact details of provider:
    Postal: Maison de la recherche en sciences de l'homme, 21 quai de la Citadelle, 59140 Dunkerque
    Phone: (33) 3 28 23 71 35
    Fax: (33) 3 28 23 71 43 or (33) 3 28 23 71 10
    Email:
    Web page: http://riifr.univ-littoral.fr/
    More information through EDIRC

    Related research

    Keywords: Rapprochement stratégique; globalisation; bio-pharmaceutique; coopération; concurrence/strategic partnership; globalization; biopharmaceutical; cooperation;

    Find related papers by JEL classification:

    References

    References listed on IDEAS
    Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.:
    as in new window
    1. Dasgupta, Partha & Stiglitz, Joseph, 1981. "Entry, innovation, exit : Towards a dynamic theory of oligopolistic industrial structure," European Economic Review, Elsevier, vol. 15(2), pages 137-158.
    2. Richardson, G B, 1972. "The Organisation of Industry," Economic Journal, Royal Economic Society, vol. 82(327), pages 883-96, September.
    3. Lyons, Bruce R., 1995. "Specific investment, economies of scale, and the make-or-buy decision: A test of transaction cost theory," Journal of Economic Behavior & Organization, Elsevier, vol. 26(3), pages 431-443, May.
    4. Rothaermel, Frank T., 2001. "Complementary assets, strategic alliances, and the incumbent's advantage: an empirical study of industry and firm effects in the biopharmaceutical industry," Research Policy, Elsevier, vol. 30(8), pages 1235-1251, October.
    5. d'ASPREMONT, Claude & JACQUEMIN, Alexis, . "Cooperative and noncooperative R&D in duopoly with spillovers," CORE Discussion Papers RP -823, Université catholique de Louvain, Center for Operations Research and Econometrics (CORE).
    6. John Hagedoorn & Rajneesh Narula, 1996. "Choosing Organizational Modes of Strategic Technology Partnering: International and Sectoral Differences," Journal of International Business Studies, Palgrave Macmillan, vol. 27(2), pages 265-284, June.
    Full references (including those not matched with items on IDEAS)

    Citations

    Lists

    This item is not listed on Wikipedia, on a reading list or among the top items on IDEAS.

    Statistics

    Access and download statistics

    Corrections

    When requesting a correction, please mention this item's handle: RePEc:rii:riidoc:90. See general information about how to correct material in RePEc.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: (Philippe Chagnon).

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If references are entirely missing, you can add them using this form.

    If the full references list an item that is present in RePEc, but the system did not link to it, you can help with this form.

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your profile, as there may be some citations waiting for confirmation.

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.